| Patents for A61P 5 - Drugs for disorders of the endocrine system (28,908) |
|---|
| 04/25/2006 | US7034025 Administering to a mammal an effective dose of a cysteine derivatives containing heteroaromatic group for the treatment of arterial tension, embryogenesis, oncogenesis, diabetes, cell proliferation, and other diseases |
| 04/25/2006 | US7034021 Dihydro-1,3,5-triazine amine derivatives and their therapeutic uses |
| 04/25/2006 | US7033794 Basolateral sorting signal and inhibitors thereof |
| 04/25/2006 | US7033597 Intracellular delivery of biological effectors |
| 04/25/2006 | CA2194885C Substituted benzamidines, their preparation and their use as pharmaceutical compounds |
| 04/20/2006 | WO2006041037A1 Novel pyridine derivative |
| 04/20/2006 | WO2006040966A1 Aromatic-ring-fused pyrimidine derivative |
| 04/20/2006 | WO2006040351A1 Indazoles, benzisoxazoles and benzisothiazoles and their use as estrogenic agents |
| 04/20/2006 | WO2006040047A2 Diagnostics and therapeutics for diseases associated with rho/rac-interacting citron kinase (cit) |
| 04/20/2006 | US20060084646 Method of preparing alkylated salicylamides via a dicarboxylate intermediate |
| 04/20/2006 | US20060083784 Amorphous pharmaceutical compositions |
| 04/20/2006 | US20060083778 Controlled release compositions of estradiol metabolites |
| 04/20/2006 | DE3991505B4 Somatostatinpeptide, deren Analoga oder Derivate, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Zusammensetzungen Somatostatin peptides, their analogues or derivatives, to processes for their preparation and pharmaceutical compositions containing them |
| 04/20/2006 | DE10127897B4 Manteltablette mit Pflanzentrockenextrakten Coated tablet with dry plant extracts |
| 04/20/2006 | CA2582180A1 Indazoles, benzisoxazoles and benzisothiazoles, process for preparing them, pharmaceutical compositions and use as estrogenic agents |
| 04/19/2006 | EP1647549A1 Indazoles, benzisoxazoles and benzisothiazoles as estrogenic agents |
| 04/19/2006 | EP1646389A1 Pyrimidine-2,4-dione derivatives as gonadotropin-releasing hormone receptor antagonists |
| 04/19/2006 | EP1474122A4 Compounds for blocking androgen receptors |
| 04/19/2006 | EP1294724B1 Pyrrolo¬2,3-d|pyrimidine compounds as immunosuppressive agents |
| 04/19/2006 | EP1276495B1 Use of recombinant pulmonary surfactant for the early treatment of acute pulmonary diseases |
| 04/19/2006 | EP1212330B1 Androgen receptor modulator compounds and methods |
| 04/19/2006 | EP1151102B1 Glycosylated leptin compositions and related methods |
| 04/19/2006 | EP0811064B1 Mpl ligand analogs |
| 04/19/2006 | CN1759840A Prescription of oxendolone drop pills and preparation method |
| 04/18/2006 | US7030157 Hormone replacment therapy; anticancer agent; sexual disorders |
| 04/18/2006 | US7030135 A sulfonylamino-tetrahydro(1,3)thiazolo(5,4-c)pyridinyl or benzothiazole derivatives, for treating diabetes, syndrome X, obesity, glaucoma, hyperlipidemia, hyperglycemia, hyperinsulinemia, osteoporosis, tuberculosis, dementia |
| 04/18/2006 | US7030112 Pyrrolopyridazine compounds and methods of use thereof for the treatment of proliferative disorders |
| 04/18/2006 | US7030104 Topical oestroprogestational compositions with a systemic effect |
| 04/18/2006 | US7029914 DNA encoding SNORF36 receptors |
| 04/18/2006 | US7029659 aqueous solvent, organic cosolvent, and occlusive agent, especially petrolatum, to form an occlusive layer on the skin for the topical administration of pharmaceuticals |
| 04/13/2006 | WO2006039243A1 Novel benzimidazole derivatives useful as selective androgen receptor modulators (sarms) |
| 04/13/2006 | WO2006039215A2 Novel benzimidazole derivatives useful as selective androgen receptor modulators (sarms) |
| 04/13/2006 | WO2006038738A1 Receptor function regulating agent |
| 04/13/2006 | WO2006038680A1 2-arylcarboxamide-nitrogeneous heterocycle compound |
| 04/13/2006 | WO2006038462A1 Novel steroid-producing cell |
| 04/13/2006 | WO2005105066A8 Histone deacetylases inhibitors against hyperlipidaemias, atherosclerosis, cardiovascular diseases |
| 04/13/2006 | US20060079685 1-(4-Bromo-benzyl)-4-(4-isopropyl-phenyl)-6-propargyloxy-1H-quinazolin-2-one;osteoporosis, bone disorders, fractures, osteopathy, osteo-malacia, periodontal bone loss or bone loss due to arthritis or osteoarthritis; for promoting the release of parathyroid hormone |
| 04/13/2006 | US20060079670 98 human secreted proteins |
| 04/13/2006 | US20060079563 Cyclic protein tyrosine kinase inhibitors |
| 04/13/2006 | US20060079460 Purified LH |
| 04/13/2006 | US20060078989 Dedifferentiated, programmable stem cells of monocytic origin, and their production and use |
| 04/13/2006 | US20060078940 21132, a human G-protein coupled receptor family member and uses therefor |
| 04/13/2006 | US20060078547 Lactobacillus salivarius strain, AH102, AH103, AH105, AH109 or AH110 or mutants or variants are useful in the prophylaxis and/or treatment undesirable gastrointestinal inflammatory activity, such as inflammatory bowel disease or irritable bowel syndrome |
| 04/13/2006 | CA2583326A1 Receptor function regulating agent |
| 04/13/2006 | CA2582356A1 Novel benzimidazole derivatives useful as selective androgen receptor modulators (sarms) |
| 04/13/2006 | CA2582347A1 Novel benzimidazole derivatives useful as selective androgen receptor modulators (sarms) |
| 04/13/2006 | CA2582327A1 2-arylcarboxamide-nitrogeneous heterocycle compound |
| 04/12/2006 | EP1645566A2 Analogs of parathyroid hormone |
| 04/12/2006 | EP1645287A2 Anhydrous topical skin preparations |
| 04/12/2006 | EP1644411A2 Stabilised insulin compositions |
| 04/12/2006 | EP1644398A1 Specific glucocorticosteroid compound having anti- inflammatory activity |
| 04/12/2006 | EP1644397A1 Specific glucocorticosteroid compound having anti- inflammatory activity |
| 04/12/2006 | EP1644385A1 Silicon compounds and their use |
| 04/12/2006 | EP1644342A1 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto |
| 04/12/2006 | EP1644321A2 New benzamides as ppaty modulators |
| 04/12/2006 | EP1409513B1 Methylene-4-azasteroids |
| 04/12/2006 | EP1263448B1 Maca and antler for augmenting testosterone levels |
| 04/12/2006 | EP1152749B1 Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicles |
| 04/12/2006 | CN1758916A Method of treating and preventing hyperparathyroidism with vitamin D2 or D4 compounds |
| 04/12/2006 | CN1250563C Androgen glycosides and androgenic activity thereof |
| 04/12/2006 | CN1250549C Indole derivatives and their use as 5-ht2b and 5-ht2c receptor ligands |
| 04/12/2006 | CN1250289C Drugs, drinks or foods |
| 04/12/2006 | CN1250288C Beta glycan as an inhibin receptor and uses thereof |
| 04/12/2006 | CN1250226C Pharmaceutical combination comprising either (S)-20ethoxy-3-[4-(2-{4-methane sulfonyl oxyphenyl} ethoxy) phenyl] propanoic acid or 3-{4-[2-(4-tboc amino-phenyl)ethoxy]phenyl}-(S)-2-ethoxy propionic ac |
| 04/11/2006 | US7026508 Succinate salt of O-desmethyl-venlafaxine |
| 04/11/2006 | US7026484 For therapy of cancer |
| 04/11/2006 | US7026335 Melanocortin receptor ligands |
| 04/11/2006 | US7026320 Serotonergic agents |
| 04/11/2006 | US7026316 (optionally aza)cycloalkyl-N,N-optionally thia-, oxothia- or dioxothia-)alkyleneglycine derivatives, e.g., N-{4-[(1S)-1-amino-2-oxo-2-(1,3-thiazolidin-3-yl)ethyl]cyclohexyl}-N'-hexylureA; especially treating type 2 diabetes |
| 04/11/2006 | US7026281 Antagonistic analogs of GH-RH inhibiting IGF-I and -II |
| 04/11/2006 | CA2372710C Laminates containing an active substance for transdermal systems |
| 04/06/2006 | WO2008034796A2 Estratriene derivatives and their uses as 17beta-hydr0xyster0id dehydrogenase inhibitors |
| 04/06/2006 | WO2006034661A1 A method for producing oral solid dosage form and oral solid dosage form prepared thereby |
| 04/06/2006 | WO2005002612A8 Composition for treating and/or preventing dysfunctions associated with type 2 diabetes mellitus and insulin resistance |
| 04/06/2006 | WO2004105768A8 Composition comprising antiprogestins and pure antiestrogens for prophylaxis and treatment of hormone-dependent diseases |
| 04/06/2006 | US20060074233 Detect binding with cells transfected with DNA |
| 04/06/2006 | US20060074128 Substituted 2-phenyl benzofurans as estrogenic agents |
| 04/06/2006 | US20060074058 Combination of dpp iv inhibitor and a cardiovascular compound |
| 04/06/2006 | US20060074027 Microcapsules of luteinizing hormone releasing hormone agonists; glycolic acid-lactic acid copolymers; for treating prostate cancer, prostatomegaly, endometriosis, hysteromyoma, metrofibroma, precocious puberty, dymenorrhea or breast cancer, or inhibiting conception |
| 04/06/2006 | US20060073567 Novel insulin/IGF/relaxin family polypeptides and DNAs thereof |
| 04/06/2006 | US20060073522 Derived from ghrelin polypeptide, labelled with fluorochrome and cysteine; drug screening; high throughput assay |
| 04/06/2006 | US20060073333 Dispersing a matrix of nanostructured liquid phase or a dehydrated variant and a nanostructured liquid crystalline phase or a dehydrated variant in nonlamellar material; cooling or evaporating a volatile solvent |
| 04/06/2006 | US20060073105 Novel dry powder inhalation system for transpulmonary administration |
| 04/05/2006 | EP1642587A1 Follicle-stimulating hormone releasing agent |
| 04/05/2006 | EP1641779A1 2-substitued 5, 6-diaryl-pyrazine derivatives as cb1 modulator. |
| 04/05/2006 | EP1641761A2 17-acetamido-4-azasteroid derivatives as androgen receptor modulators |
| 04/05/2006 | EP1641745A1 Propionamide derivatives useful as androgen receptor modulators |
| 04/05/2006 | EP1641535A2 17-acetamido-4-azasteroid derivatives as androgen receptor modulators |
| 04/05/2006 | EP1641464A2 17-acetamido-4-azasteroid derivatives as androgen receptor modulators |
| 04/05/2006 | EP1438104B1 Co-cycloalkyl 17-heteroaryl prostaglandin e2 analogs as ep2-receptor agonists |
| 04/05/2006 | EP1300398B1 Propane-1,3-dione derivatives |
| 04/05/2006 | EP0981514B1 3-epi vitamin d2 compounds and uses thereof |
| 04/05/2006 | CN1756561A Immunotherapy of B cell malignancies and autoimmune diseases using unconjugated antibodies and conjugated antibodies and antibody combinations and fusion proteins |
| 04/05/2006 | CN1249087C Novel human G-Protein coupled receptor |
| 04/05/2006 | CN1249086C Melanocortin receptor ligands |
| 04/05/2006 | CN1249056C Inhibitors of dipeptidyl peptidase IV |
| 04/05/2006 | CN1249039C Inhibitors of 11-beta-hydroxy steroid dehydrogenase type I |
| 04/05/2006 | CN1249033C Cyclic amp-specific phosphodiesterase inhibitors |
| 04/05/2006 | CN1248738C Testosterone ester formulation for human use |
| 04/05/2006 | CN1248732C Embonate medicine composition containing bombesin-like product |